Hyperhomocysteinemia was all the rage a few years ago. Sadly, as is often the case, trials to lwoer homocysteine failed to show much clinical benefit. Now comes a trial to test the effect of follic acid, on CKD prevention. With an N > 15,000 - this should make for an interesting NephJC discussion.